Sumitomo Pharma Co., Ltd.: all 273 studies

Page 1 of 3. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis PigmentosaRecruitingNCT06891885Phase 1/2
• A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's DiseaseRecruitingNCT06753331Phase 1/2
• SMP-3124LP in Adults With Advanced Solid TumorsRecruitingNCT06526819Phase 1/2
• A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisRecruitingNCT05862272Phase 3
• Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their OffspringRecruitingNCT05739123
• Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CICRecruitingNCT05491525Phase 2/3
• Congenital Athymia Patient RegistryRecruitingNCT05329935
• A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)RecruitingNCT04988555Phase 1/2
• A Study of Oral Nuvisertib (TP-3654) in Patients With MyelofibrosisRecruitingNCT04176198Phase 1/2
• A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.CompletedNCT06037668Not applicableResults posted
• Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide AcetateCompletedNCT05605964Phase 3Results posted
• A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).TerminatedNCT05227209Phase 3Results posted
• A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.TerminatedNCT05169710Phase 3Results posted
• Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for PregnancyCompletedNCT04756037Phase 3Results posted
• A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)CompletedNCT04712669Phase 2Results posted
• A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDSTerminatedNCT04623996Phase 1/2Results posted
• URO-902 in Female Subjects With Overactive Bladder and Urge Urinary IncontinenceCompletedNCT04211831Phase 2Results posted
• A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.CompletedNCT04155047Phase 4Results posted
• Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic HyperplasiaCompletedNCT04103450Phase 3Results posted
• Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination TherapyTerminatedNCT03969420Phase 2Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)CompletedNCT03902080Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel SyndromeCompletedNCT03806127Phase 2Results posted
• Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT03751124Phase 3Results posted
• SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated PainCompletedNCT03654274Phase 3Results posted
• A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With SchizophreniaCompletedNCT03627195Phase 1Results posted
• A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDSTerminatedNCT03593915Phase 1/2Results posted
• An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).CompletedNCT03583372Phase 3Results posted
• Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLLTerminatedNCT03572634Phase 1/2Results posted
• A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 DepressionCompletedNCT03543410Phase 2Results posted
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)CompletedNCT03492281Phase 3Results posted
• A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic ProfileTerminatedNCT03416335Phase 1/2Results posted
• LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT03412890Phase 3Results posted
• A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)CompletedNCT03391882Phase 3Results posted
• A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid TumorsTerminatedNCT03311334Phase 1/2Results posted
• Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).CompletedNCT03298984Phase 1Results posted
• A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" EpisodesCompletedNCT03292016Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.CompletedNCT03231800Phase 3Results posted
• A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" EpisodesCompletedNCT03187301Phase 2Results posted
• A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial TherapyCompletedNCT03149003Phase 3Results posted
• A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset SeizuresCompletedNCT03116828Phase 4Results posted
• A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating DisorderCompletedNCT03107026Phase 3Results posted
• LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT03103087Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate CancerCompletedNCT03085095Phase 3Results posted
• LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT03049735Phase 3Results posted
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic AdenocarcinomaCompletedNCT02993731Phase 3Results posted
• Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02951312Phase 2Results posted
• Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02948582Phase 2Results posted
• A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung CancerTerminatedNCT02826161Phase 3Results posted
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT02753127Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.CompletedNCT02734693Phase 3Results posted
• Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for EDCompletedNCT02713789Phase 2Results posted
• Dasotraline Binge Eating Disorder Extension StudyCompletedNCT02684279Phase 3Results posted
• Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's DiseaseCompletedNCT02542696Phase 3Results posted
• Alvocidib Biomarker-driven Phase 2 AML StudyTerminatedNCT02520011Phase 2Results posted
• Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT02512302Phase 1Results posted
• Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)CompletedNCT02491073Results posted
• Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's DiseaseCompletedNCT02469090Phase 3Results posted
• Dasotraline Pediatric Extension StudyCompletedNCT02457819Phase 3Results posted
• A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 ElevationTerminatedNCT02432690Phase 2Results posted
• A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural MesotheliomaCompletedNCT02347917Phase 1/2Results posted
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)CompletedNCT02347774Phase 3Results posted
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPDCompletedNCT02347761Phase 3Results posted
• Long-term Study of DSP-5423P in Patients With SchizophreniaCompletedNCT02335658Phase 3Results posted
• A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed GlioblastomaCompletedNCT02315534Phase 1/2Results posted
• Confirmatory Study of DSP-5423P in Patients With SchizophreniaCompletedNCT02287584Phase 3Results posted
• A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular CarcinomaCompletedNCT02279719Phase 1/2Results posted
• A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPDCompletedNCT02276222Phase 3Results posted
• A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) SubjectsTerminatedNCT02275481Phase 4Results posted
• Expanded Access Protocol Thymus TransplantationCompletedNCT02274662Phase 4Results posted
• A Study to Examine APL-130277 in Patients With Parkinson's DiseaseCompletedNCT02228590Phase 2Results posted
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction CancerCompletedNCT02178956Phase 3Results posted
• Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human SubjectsCompletedNCT02174523Phase 1Results posted
• A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy SubjectsCompletedNCT02174510Phase 1Results posted
• A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric SubjectsTerminatedNCT02150499Phase 3Results posted
• Lurasidone Pediatric Bipolar StudyCompletedNCT02046369Phase 3Results posted
• A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPDCompletedNCT02038829Phase 2Results posted
• A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal CancerCompletedNCT02024607Phase 1/2Results posted
• A Clinical Trial of Lurasidone in Treatment of SchizophreniaCompletedNCT02002832Phase 3Results posted
• A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.CompletedNCT01986114Phase 3Results posted
• A Phase III Study of SM-13496 in Patients With Bipolar I Depression.CompletedNCT01986101Phase 3Results posted
• Pediatric Open-Label Extension StudyCompletedNCT01914393Phase 3Results posted
• Lurasidone Pediatric Autism StudyCompletedNCT01911442Phase 3Results posted
• Pediatric Schizophrenia Efficacy and Safety StudyCompletedNCT01911429Phase 3Results posted
• Lurasidone Low-Dose - High-Dose Study StudyCompletedNCT01821378Phase 3Results posted
• A Study of BBI608 in Adult Patients With Advanced Colorectal CancerCompletedNCT01776307Phase 2Results posted
• A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01706536Phase 2Results posted
• Adult Attention Deficit Hyperactivity DisorderCompletedNCT01692782Phase 2Results posted
• A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)CompletedNCT01654536Phase 4Results posted
• Clinical Study of WT2725 in Patients With Advanced MalignanciesCompletedNCT01621542Phase 1Results posted
• Lurasidone Pediatric Pharmacokinetics StudyCompletedNCT01620060Phase 1Results posted
• Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedNCT01614912Phase 3Results posted
• A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedNCT01614899Phase 3Results posted
• This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296CompletedNCT01575561Phase 3Results posted
• A Twelve Week, Open Label Extension Study in Patients With SchizophreniaCompletedNCT01566162Phase 3Results posted
• Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With RisperidoneCompletedNCT01516424Phase 3Results posted
• Lurasidone Extended Use StudyCompletedNCT01485640Phase 3Results posted
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)CompletedNCT01458275Phase 3Results posted
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).CompletedNCT01451541Phase 3Results posted
• PEARL Schizophrenia MaintenanceCompletedNCT01435928Phase 3Results posted
• Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 StudyCompletedNCT01426009Phase 2Results posted

← Sumitomo Pharma Co., Ltd. overview and focus areas